Top Clinical Trials companies in Australia by EPS (Diluted)

This ranking features the top 15 Clinical Trials companies in Australia ranked by EPS (Diluted), averaging a EPS (Diluted) of USD -0.29, for February 07, 2025.
#
Name
EPS (Diluted)
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 5.45
June 30, 2024 USD 171.50 0.95%

Australia

2
USD 0.47
June 30, 2024 USD 7.25 -0.16%

Australia

3
USD 0.08
June 30, 2024 USD 2.33 0.29%

Australia

4
USD 0.03
June 30, 2024 USD 0.74 0.02%

Australia

5
USD 0.01
Dec. 31, 2023 USD 18.31 -0.05%

Australia

6
USD 0.01
June 30, 2024 USD 1.23 0.02%

Australia

7
USD -0.00
June 30, 2024 USD 4.80 5.03%

Australia

8
USD -0.01
June 30, 2024 USD 0.74 0.02%

Australia

9
USD -0.02
June 30, 2024 USD 2.04 -5.56%

Australia

10
USD -0.02
June 30, 2024 USD 2.09 0.97%

Australia

11
USD -0.09
June 30, 2024 USD 1.84 -3.30%

Australia

12
USD -0.10
June 30, 2024 USD 2.34 -4.83%

Australia

13
USD -0.35
June 30, 2024 NA

Australia

14
USD -1.14
June 30, 2024 USD 1.67 2.45%

Australia

15
USD -2.94
Dec. 31, 2023 USD 6.22 1.04%

Australia

Frequently Asked Questions
  • Which Clinical Trials company in Australia has the highest EPS (Diluted) ?

    The Clinical Trials company in Australia with the highest EPS (Diluted) is CSL Limited (ASX: CSL.AX) at USD 5.45.

  • Which Clinical Trials company in Australia has the lowest EPS (Diluted) ?

    The Clinical Trials company in Australia with the lowest EPS (Diluted) is Anteris Technologies Ltd (ASX: AVR.AX) at USD -2.94.

SV Wall Street